[CURRENT REPORT FOR ISSUERS SUBJECT TO THE Amendment No. 2 to FORM 8-K CURRENT REPORT June 6, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041]
[Item 5.07. Submission of Matters to a Vote of Security Holders. The following proposals were submitted to the stockholders of Sohu.com Inc. (Sohu) at the annual meeting of stockholders held on June 20, 2014: 1. Election of two directors, to serve for a two-year term or until their earlier death, resignation or removal; 2. Advisory resolution approving Sohus executive compensation;]
[Issuer Free Writing Prospectus dated June 23, 2014 Relating to Preliminary Prospectus Supplement dated June 17, 2014 to Prospectuses dated December 16, 2010, July 23, 2012 and June 17, 2014 Registration Nos. 333-171069 333-182624 and 333-196591 The following information supplements and updates the information contained in the Company’s preliminary prospectus supplement dated June 23, 2014. All references to page numbers]
[Issuer Free Writing Prospectus dated June 23, 2014 Relating to Preliminary Prospectus Supplement dated June 17, 2014 to Prospectuses dated December 16, 2010, July 23, 2012 and June 17, 2014 Registration Nos. 333-171069 333-182624 and 333-196591 The following information supplements and updates the information contained in the Company’s preliminary prospectus supplement dated June 23, 2014. All references to page numbers]
[China Biologic Announces Favorable Reduction in Value Added Tax Rate BEIJING, China – June 23, 2014 About China Biologic China Biologic is a leading plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and] []
[China Biologic Announces Favorable Reduction in Value Added Tax Rate BEIJING, China – June 23, 2014 About China Biologic China Biologic is a leading plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and] []
[Bona Film Group Announces Transition of Amy W. Xu from CFO to Senior Advisor Financial Controller Nicolas Zhi Qi Named Chief Financial Officer BEIJING, June 20, 2014 Bona Film Group Limited (Bona or the Company) (NASDAQ: BONA), a leading film distributor and vertically integrated film company in China, today announced that Amy W. Xu will transition from her position] [TABLE OF CONTENTS 2 BONA FILM GROUP LIMITED]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]
